Search Press releases

Press releases teaser image
7 Mar 2025

Share Repurchase Program 2025 to cover UCB's Long Term Incentive Plans for employees

Read More
Press releases teaser image
7 Mar 2025

BIMZELX[®] (bimekizumab-bkzx) five-year data at AAD 2025 showed sustained skin clearance and long-term efficacy in moderate-to-severe plaque psoriasis

Read More
Press releases teaser image
7 Mar 2025

BIMZELX[®] (bimekizumab-bkzx) two-year data at AAD showed potential to eliminate draining tunnels in hidradenitis suppurativa (HS), and reduction in disease burden

Read More
Press releases teaser image
27 Feb 2025

On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth

Read More
Press releases teaser image
12 Feb 2025

BIMZELX[®]▼(bimekizumab) two-year data at EHSF 2025 demonstrate sustained disease control in hidradenitis suppurativa (HS)

Read More
Press releases teaser image
31 Jan 2025

RYSTIGGO[®]▼(rozanolixizumab), for generalized myasthenia gravis (gMG), receives EU approval for two new administration methods

Read More

Stay up-to-date on the latest news and information from UCB